Premium Nahrungsergänzungsmittel | artgerecht

Postmenopausal Osteoporosis: Causes & Treatment

Postmenopausal osteoporosis is a bone-thinning disease caused by estrogen deficiency after menopause, significantly increasing the risk of fractures.

Regular tips about health Regular tips about health

Things worth knowing about "Postmenopausal osteoporosis"

Postmenopausal osteoporosis is a bone-thinning disease caused by estrogen deficiency after menopause, significantly increasing the risk of fractures.

What is postmenopausal osteoporosis?

Postmenopausal osteoporosis is a skeletal disease in which bone density and bone quality decline after menopause – the permanent cessation of menstrual periods. The primary cause is a drop in estrogen, a female sex hormone that normally protects bone tissue. Without adequate estrogen, bone is broken down faster than it is rebuilt, leaving the skeleton fragile and prone to fractures.

Osteoporosis is often called a "silent disease" because it typically develops without pain and is only discovered when a bone breaks. The most common fracture sites are the spine, hip, and wrist.

Causes

The key trigger of postmenopausal osteoporosis is the sharp decline in estrogen levels after the last menstrual period. Estrogen normally suppresses the activity of osteoclasts (bone-resorbing cells). When this protective effect is lost, bone resorption accelerates.

Additional risk factors include:

Early menopause (before age 45)
Family history of osteoporosis or fractures
Calcium and vitamin D deficiency
Physical inactivity
Smoking and excessive alcohol consumption
Long-term use of corticosteroids
Low body weight

Symptoms

In the early stages, postmenopausal osteoporosis causes no symptoms. Over time, the following signs may appear:

Back pain due to vertebral fractures
Loss of height and a stooped posture (kyphosis)
Bone fractures from minimal trauma (e.g., a low-level fall)
Sudden, severe back pain indicating a vertebral compression fracture

Diagnosis

The gold standard for diagnosis is bone density measurement by DXA scanning (Dual-Energy X-ray Absorptiometry). It produces a T-score:

T-score ≥ -1.0: normal
T-score between -1.0 and -2.5: osteopenia (early bone loss)
T-score ≤ -2.5: osteoporosis

Blood tests (e.g., calcium, vitamin D, bone turnover markers) and X-ray imaging may complement the diagnosis.

Treatment

General measures

Foundation therapy for all patients includes:

Calcium (1000–1200 mg/day) and vitamin D (800–1000 IU/day) supplementation
Regular physical activity, especially weight-bearing and balance exercises
Fall prevention strategies in daily life
Avoiding smoking and excessive alcohol intake

Pharmacological therapy

When fracture risk is elevated, several medications are available:

Bisphosphonates (e.g., alendronate, risedronate): inhibit bone resorption; first-line treatment
Denosumab: a monoclonal antibody that blocks osteoclast activity
Raloxifene: a selective estrogen receptor modulator (SERM)
Teriparatide and romosozumab: bone-building agents for severe osteoporosis
Hormone replacement therapy (HRT): may be considered in younger postmenopausal women after careful benefit-risk assessment

Prevention

Building optimal bone mass during younger years through adequate calcium, vitamin D, and physical activity is the best long-term strategy. After menopause, early medical evaluation is recommended to detect and treat osteoporosis before fractures occur.

References

World Health Organization (WHO): Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843, Geneva, 1994.
Kanis JA et al. on behalf of the Scientific Advisory Board of ESCEO: European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International, 2019;30(1):3–44.
National Osteoporosis Foundation (NOF): Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington DC, 2022.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.